3D Medicines, Inc. (HK:1244) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
3D Medicines Inc. has announced its upcoming annual general meeting scheduled for June 28, 2024, where they will address key corporate matters including the adoption of the audited financial statements for 2023, re-election of directors, and appointment of a new auditor. Shareholders will consider resolutions pertaining to director remuneration and the authorization for the board to issue additional shares or convertible securities.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.